Harvard Bioscience Inc HBIO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 10:50 AM EDT
3.92quote price arrow up+0.10 (+2.62%)
Volume
8,784
52 week range
3.44 - 6.28
Loading...
  • Open3.89
  • Day High3.94
  • Day Low3.83
  • Prev Close3.82
  • 52 Week High6.28
  • 52 Week High Date05/04/23
  • 52 Week Low3.44
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap170.211M
  • Shares Out43.42M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change-26.92

KEY STATS

  • Open3.89
  • Day High3.94
  • Day Low3.83
  • Prev Close3.82
  • 52 Week High6.28
  • 52 Week High Date05/04/23
  • 52 Week Low3.44
  • 52 Week Low Date04/26/24
  • Market Cap170.211M
  • Shares Out43.42M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change-26.92

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-48.82
  • Fwd P/E (NTM)18.94
  • EBITDA (TTM)8.892M
  • ROE (TTM)-4.70%
  • Revenue (TTM)112.25M
  • Gross Margin (TTM)58.86%
  • Net Margin (TTM)-3.04%
  • Debt To Equity (MRQ)50.04%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harvard Bioscience Inc

 

Profile

MORE
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and...
James Green
Chairman of the Board, President, Chief Executive Officer
Jennifer Cote
Chief Financial Officer, Treasurer
Address
84 OCTOBER HILL RD
Holliston, MA
01746
United States

Top Peers

SYMBOLLASTCHG%CHG
RIGL
Rigel Pharmaceuticals Inc
1.20+0.05+3.91%
CTMX
CytomX Therapeutics Inc
4.69+0.19+4.22%
TSVT
2Seventy Bio Inc
4.85-0.08-1.62%
SPRO
Spero Therapeutics Inc
1.64+0.02+1.55%
ENZ
Enzo Biochem Inc
1.05+0.01+1.44%